Jennifer Tousignant
Chief Legal Officer & Corporate SecretaryMs. Jennifer Tousignant, J.D., serves as Chief Legal Officer & Corporate Secretary of Viridian Therapeutics, Inc. from February 16, 2024. She served as Senior Vice President of Legal at Sana Biotechnology, Inc. since September 2022 until 2024. She has broad legal experience and leadership in the biotechnology industry working across a breadth of technologies such as small molecules, biologics, cell and gene therapies and in the therapeutic categories of rare disease, immune-mediated disease, neurodegenerative disease and oncology. She joined Sana from Xilio Therapeutics where she was the Head of Legal and responsible for all legal and compliance matters, including business development, corporate governance, financings, intellectual property, litigation, quality, research and development and transactional work. Prior to Xilio, she was Chief IP Counsel at TESARO, Inc. where she built and led the intellectual property function, was a key Member of the global launch teams for Varubi, Zejula, Varuby and the prelaunch team for Jemperli. Additionally, she played key legal roles in TESARO’s transactional work, public financings and in its acquisition by GSK. Before TESARO, she worked at Genzyme Corporation (acquired by Sanofi) in roles of increasing responsibility, first in research and then in legal and ultimately leading a legal team with worldwide intellectual property responsibility for products from early research to commercial, including small molecules, biologics and gene therapy products. During her time at Genzyme, she was a Member of the global launch teams for Kynamro, Cerdelga and Lemtrada and acted as a primary counsel supporting the business development teams of the rare disease and multiple sclerosis business units. She received her JD from Suffolk University School of Law, magna cum laude and her BA in Chemistry with Honors from the University of Virginia.
Positions
- Company NameViridian Therapeutics, Inc.Stock CodeVRDNPositionChief Legal Officer & Corporate SecretaryColleagues
- SFStephen F. MahoneyCEO, President & Director
- TKTomas KiselakIndependent Chairperson of Board
- SHSeth HarmonChief Financial Officer
- TWThomas W. BeethamChief Operating Officer
- RTRadhika TripuraneniChief Medical Officer
- ENEric N. OlsonCo-Founder & Chairman of Scientific Advisory Board
- MRMichael R. BristowCo-Founder & Member of the Scientific Advisory Board
- MHMarvin H. CaruthersCo-Founder & Scientific Advisory Board Member
